2023
Costs and cost‐effectiveness of a collaborative data‐to‐care intervention for HIV treatment and care in the United States
Shrestha R, Fanfair R, Randall L, Lucas C, Nichols L, Camp N, Brady K, Jenkins H, Altice F, DeMaria A, Villanueva M, Weidle P. Costs and cost‐effectiveness of a collaborative data‐to‐care intervention for HIV treatment and care in the United States. Journal Of The International AIDS Society 2023, 26: e26040. PMID: 36682053, PMCID: PMC9867888, DOI: 10.1002/jia2.26040.Peer-Reviewed Original ResearchConceptsCare armHIV careCare patientsIntervention armCare interventionsHealth departmentsHIV care interventionsHIV care outcomesHIV care providersHealthcare provider perspectiveHIV clinicHIV treatmentCare providersControl trialCare outcomesMicrocosting approachCare programCare servicesSurveillance dataSimilar interventionsIncremental costIntervention costsProvider perspectivesCareAverage cost
2020
Assessing mobile health feasibility and acceptability among HIV-infected cocaine users and their healthcare providers: guidance for implementing an intervention
Brown SE, Krishnan A, Ranjit YS, Marcus R, Altice FL. Assessing mobile health feasibility and acceptability among HIV-infected cocaine users and their healthcare providers: guidance for implementing an intervention. MHealth 2020, 6: 4-4. PMID: 32190615, PMCID: PMC7063267, DOI: 10.21037/mhealth.2019.09.12.Peer-Reviewed Original ResearchMedication adherenceHealthcare providersCocaine useFeasibility of mHealthHIV treatment outcomesCocaine usersCommunity health workersSelf-reported cocaine usePatient-provider relationshipPhone callsPharmacological treatmentText remindersTreatment outcomesHealth workersControl trialFocus groupsMHealth interventionsPatientsHIVMHealth pilotsCost-effective strategyCase managersHealth informationHealth purposesAdherence
2018
Prevalence, Diagnosis, and Treatment Rates of Mood Disorders among Opioid Users under Criminal Justice Supervision
Mbaba M, Brown SE, Wooditch A, Kiss M, Murphy A, Kumari S, Taxman F, Altice F, Lawson WB, Springer SA. Prevalence, Diagnosis, and Treatment Rates of Mood Disorders among Opioid Users under Criminal Justice Supervision. Substance Use & Misuse 2018, 53: 1519-1528. PMID: 29333954, PMCID: PMC6432769, DOI: 10.1080/10826084.2017.1416400.Peer-Reviewed Original ResearchConceptsPatient Health Questionnaire-9Mood disordersBipolar disorderOpioid usersAddiction Severity Index-LiteOpioid use treatmentCriminal justice supervisionOpioid-dependent individualsSelf-reported mood disordersOpioid-dependent populationsComprehensive psychiatric careAdverse health consequencesLarger parent studyLifetime suicide attemptsHigh rateQuestionnaire-9Positive screenJustice-involved individualsSevere depressionTreatment utilizationGeneral U.S.Psychiatric careControl trialParent studyPsychiatric disorders
2017
Assessing Feasibility and Acceptability of mHealth among Underserved HIV+ Cocaine Users and Their Healthcare Providers
Brown S, Krishnan A, Ranjit Y, Marcus R, Altice F. Assessing Feasibility and Acceptability of mHealth among Underserved HIV+ Cocaine Users and Their Healthcare Providers. Iproceedings 2017, 3: e48. DOI: 10.2196/iproc.8676.Peer-Reviewed Original ResearchGroup of HIVText remindersCocaine usersDrug treatment clinicsFeasibility of mHealthHIV treatment outcomesSelf-reported cocaine useRisk of transmissionAcceptability of mHealthPhone callsViral suppressionAntiretroviral medicationsMobile medical unitsUnstable living conditionsHIV statusMedication adherenceSubstance use providersTreatment clinicsTreatment outcomesPharmacological interventionsControl trialHIVAdherence behaviorMHealth interventionsHealth behaviors